The Evidence

Exposure vigilance: why caution follows repeated reactions — it does not create them

Exposure vigilance is the protective attention that can develop after repeated, reproducible physical reactions to environmental exposures. In MCS, caution can be a consequence of the illness rather than its cause. Repeated reactions can teach a person to scan environments, avoid known triggers, and notice patterns; that does not establish that fear, expectation, or attention created the original physiological response.

A name for one of the most misunderstood consequences of living with unpredictable chemical exposures.

What exposure vigilance is

People with MCS often become unusually attentive to the air around them, the products people use, traffic exhaust, cleaning chemicals, new building materials, fragrances, smoke, renovations, and other possible sources. From the outside, that behavior can look like anxiety or “hypervigilance.” From the inside, it can be learned protection after repeated illness in places where the exposure was invisible, unexpected, or only identified afterward.

We use the term exposure vigilance for that protective attention. It is an editorial and research term, not a new diagnosis. It names a sequence that has often been reversed in discussions of MCS: the body reacts; the person begins looking for the source; repeated experience creates caution. Caution does not automatically become the cause of the earlier reaction.

Why the direction of causation matters

The psychological model often points to vigilance, avoidance, and expectation as evidence that the brain is generating symptoms. Those processes can affect later symptom intensity, and conditioning can become part of an established illness. But they cannot be assumed to explain onset without chronology showing that they came first.

That is why the strongest question is not “Is this person watching for chemicals?” It is “What happened before they learned to watch?” Did symptoms begin before the person suspected an environmental cause? Did reactions occur before a trigger was recognized? Did the person become cautious only after being repeatedly made ill? Those questions protect the causal arrow from being reversed.

The real-world problem: exposures are often invisible

MCS is unusually difficult because real-world exposures are not neatly labeled. A person may become ill during a drive, in a store, in a medical office, or in a building without knowing exactly which compound, mixture, dose, or source was responsible. Sometimes the source becomes obvious later; sometimes it never does.

That uncertainty naturally changes behavior. A person who cannot predict when the next reaction will happen may check rooms before entering, avoid known problem environments, notice odors more quickly, or leave when symptoms begin. Those actions are not proof of phobia. They may be the practical behavior of someone managing a condition whose triggers are difficult to see and difficult to quantify.

Exposure vigilance can still become burdensome

Protective vigilance can become exhausting. It can increase stress, narrow a person’s life, and interact with autonomic arousal. Some people may also develop conditioned responses to cues associated with prior illness. Those secondary processes deserve treatment when they cause distress or unnecessary restriction.

But the outcome must be named correctly. Reducing fear is reducing fear. Improving coping is improving coping. Helping someone distinguish a conditioned cue from a real exposure is useful. None of those outcomes proves that exposure vigilance caused consensus-defined MCS or that chemical tolerance has been restored.

Why exposure reduction does not become “fear avoidance” by default

The established MCS criteria themselves include improvement or resolution when incitants are removed. In the 917-person treatment survey, chemical avoidance and a chemical-free living space were rated above the other approaches participants had tried. Real-life exposure monitoring has also linked symptoms with exposure periods, and measured reductions in indoor VOCs have tracked with symptom improvement in an environmental intervention.

Those findings do not mean every avoided situation is dangerous or that maximal isolation is healthy. They do mean that reducing exposures which repeatedly make a person ill has a stronger evidence base than simply assuming that avoidance is maintaining the illness. The goal is exposure control that protects health and function while research works toward restored tolerance.

What the registry is answering

The Canary Registry should measure the chronology of exposure vigilance rather than merely asking whether a person is “hypervigilant.” When did physical symptoms begin? When did the person first suspect an environmental cause? When did they begin actively avoiding exposures? Did reactions occur before the source was recognized? Did exposure reduction change symptoms or function?

That sequence can separate illness-first vigilance from vigilance-first theories and identify the subgroup in whom conditioned fear or learned cue responses may later have become an important secondary layer.

Where we stand

Exposure vigilance is not evidence that MCS is psychological. It is often the predictable result of living with reproducible reactions to exposures that are hard to see, identify, or control.

The strongest framing is simple: repeated physical reactions can create caution; caution did not therefore create the reactions. Psychology can shape how a person carries the illness and can amplify some responses, but the causal direction must be demonstrated, not assumed.

We followed the evidence. Here’s where it leads →

Sources

Sources

1(no author) et al. Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health 1999;54(3):147-9. PMID: 10444033. DOI: 10.1080/00039899909602251
2Gibson PR, Elms AN, Ruding LA. Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Environ Health Perspect 2003;111(12):1498-504. PMID: 12948890. DOI: 10.1289/ehp.5936
3Saito M et al. Symptom profile of multiple chemical sensitivity in actual life. Psychosom Med 2005;67(2):318-25. PMID: 15784800. DOI: 10.1097/01.psy.0000155676.69030.28
4Perales RB et al. Does improving indoor air quality lessen symptoms associated with chemical intolerance?. Prim Health Care Res Dev 2022;23:e3. PMID: 35019834. DOI: 10.1017/S1463423621000864
5Das-Munshi J, Rubin GJ, Wessely S. Multiple chemical sensitivities: A systematic review of provocation studies. J Allergy Clin Immunol 2006;118(6):1257-64. PMID: 17137865. DOI: 10.1016/j.jaci.2006.07.046
← Back to MCSDisability.com
↑